LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 28 filers reported holding LEAP THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $210,348 | +75564.7% | 618,673 | 0.0% | 0.00% | – |
Q4 2022 | $278 | -99.9% | 618,673 | +1.6% | 0.00% | – |
Q3 2022 | $535,000 | -23.6% | 608,765 | 0.0% | 0.00% | – |
Q2 2022 | $700,000 | -34.3% | 608,765 | 0.0% | 0.00% | – |
Q1 2022 | $1,065,000 | -41.9% | 608,765 | +7.7% | 0.00% | – |
Q4 2021 | $1,832,000 | +16.6% | 565,483 | +44.3% | 0.00% | – |
Q3 2021 | $1,571,000 | +161.0% | 391,893 | +6.7% | 0.00% | – |
Q2 2021 | $602,000 | -9.2% | 367,321 | +5.1% | 0.00% | – |
Q1 2021 | $663,000 | -1.3% | 349,441 | +16.8% | 0.00% | – |
Q4 2020 | $672,000 | +101.2% | 299,051 | +76.8% | 0.00% | – |
Q3 2020 | $334,000 | +9.2% | 169,162 | +15.5% | 0.00% | – |
Q2 2020 | $306,000 | +29.7% | 146,513 | -1.9% | 0.00% | – |
Q1 2020 | $236,000 | -35.9% | 149,378 | -54.6% | 0.00% | – |
Q4 2019 | $368,000 | +91.7% | 328,986 | +100.0% | 0.00% | – |
Q3 2019 | $192,000 | -34.7% | 164,493 | 0.0% | 0.00% | – |
Q2 2019 | $294,000 | +47.0% | 164,493 | +53.7% | 0.00% | – |
Q1 2019 | $200,000 | +31.6% | 107,013 | +40.4% | 0.00% | – |
Q4 2018 | $152,000 | -48.6% | 76,234 | +100.0% | 0.00% | – |
Q3 2018 | $296,000 | -4.5% | 38,117 | +10.4% | 0.00% | – |
Q2 2018 | $310,000 | – | 34,517 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|